Home
All Journals
Expert Opinion on Drug Safety
List of Issues
Volume 7, Issue 5

Expert Opinion on Drug Safety

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Drug Safety, Volume 7, Issue 5 (2008)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Drug Safety, Volume 7, Issue 5 (2008)

See all volumes and issues

Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Volume 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Article

Varenicline and suicidality: a new era in medication safety surveillance

Roger S McIntyre MD FRCPC

Pages: 511-514

Published online: 01 Sep 2008

First Page PreviewforVarenicline and suicidality: a new era in medication safety surveillance | Full Text | References | PDF (201.8 KB)

162 Views
8 CrossRef citations
0Altmetric

Reviews

Article

Safety of ceftriaxone sodium at extremes of age

Scott V Monte PharmD, William Allan Prescott Jr PharmD, Kristin K Johnson PharmD, Lori Kuhman PharmD & Joseph A Paladino PharmD

Pages: 515-523

Published online: 01 Sep 2008

AbstractforSafety of ceftriaxone sodium at extremes of age | Full Text | References | PDF (246.3 KB)

512 Views
33 CrossRef citations
0Altmetric

Review

Article

The safety of clozapine in the elderly

Pietro Gareri MD PhD, Pasquale De Fazio MD, Emilio Russo, Norma Marigliano, Salvatore De Fazio MD & Giovambattista De Sarro MD

Pages: 525-538

Published online: 01 Sep 2008

AbstractforThe safety of clozapine in the elderly | Full Text | References | PDF (1.7 MB)

731 Views
45 CrossRef citations
0Altmetric

Article

Risk of skin cancer in the drug treatment of rheumatoid arthritis

Eliza F Chakravarty MD MS & Evan R Farmer MD

Pages: 539-546

Published online: 01 Sep 2008

AbstractforRisk of skin cancer in the drug treatment of rheumatoid arthritis | Full Text | References | PDF (244.3 KB)

186 Views
13 CrossRef citations
0Altmetric

Article

Efficacy and safety of aromatase inhibitors in early breast cancer

Sundus Ozair & Shabana Iqbal MSc FRCS

Pages: 547-558

Published online: 01 Sep 2008

AbstractforEfficacy and safety of aromatase inhibitors in early breast cancer | Full Text | References | PDF (209 KB)

87 Views
3 CrossRef citations
0Altmetric

Article

Maraviroc, risks and benefits: a review of the clinical literature

Jetske M Emmelkamp & Jürgen K Rockstroh

Pages: 559-569

Published online: 01 Sep 2008

AbstractforMaraviroc, risks and benefits: a review of the clinical literature | Full Text | References | PDF (370.4 KB)

231 Views
11 CrossRef citations
0Altmetric

Article

The use and safety of doxycycline hyclate and other second-generation tetracyclines

Barry Sloan DO & Noah Scheinfeld MD JD

Pages: 571-577

Published online: 01 Sep 2008

AbstractforThe use and safety of doxycycline hyclate and other second-generation tetracyclines | Full Text | References | PDF (248 KB)

1398 Views
90 CrossRef citations
0Altmetric

Article

The safety of rosiglitazone in the treatment of Type 2 diabetes

Sonal Singh MD MPH & Yoon K Loke MBBS MD

Pages: 579-585

Published online: 01 Sep 2008

AbstractforThe safety of rosiglitazone in the treatment of Type 2 diabetes | Full Text | References | PDF (234.6 KB)

159 Views
14 CrossRef citations
0Altmetric

Article

Drug-induced serotonin syndrome: a review

Christina Sun-Edelstein MD, Stewart J Tepper MD & Robert E Shapiro MD PhD

Pages: 587-596

Published online: 01 Sep 2008

AbstractforDrug-induced serotonin syndrome: a review | Full Text | References | PDF (256.1 KB)

2581 Views
106 CrossRef citations
0Altmetric

Article

Safety of drug-coated stents

Giuseppe GL Biondi-Zoccai MD, Claudio Moretti MD, Marzia Lotrionte MD & Imad Sheiban MD

Pages: 597-606

Published online: 01 Sep 2008

AbstractforSafety of drug-coated stents | Full Text | References | PDF (258.2 KB)

142 Views
8 CrossRef citations
0Altmetric

Article

Thiopurine hepatotoxicity in inflammatory bowel disease: the role for adding allopurinol

Rupert WL Leong MBBS MD FRACP, Richard B Gearry MBChB PhD FRACP & Miles P Sparrow MBBS FRACP

Pages: 607-616

Published online: 01 Sep 2008

AbstractforThiopurine hepatotoxicity in inflammatory bowel disease: the role for adding allopurinol | Full Text | References | PDF (270.7 KB)

391 Views
28 CrossRef citations
0Altmetric

Drug Safety Evaluation

Article

Long-term treatment with infliximab in inflammatory bowel disease: safety and tolerability issues

Renato Caviglia MD PhD, Ivo Boškoski MD & Michele Cicala MD PhD

Pages: 617-632

Published online: 01 Sep 2008

AbstractforLong-term treatment with infliximab in inflammatory bowel disease: safety and tolerability issues | Full Text | References | PDF (300.5 KB)

437 Views
28 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Pembrolizumab for recurrent locally advanced or metastatic squamous cell carcinoma of the esophagus: a drug safety evaluation

Kazumasa Yamamoto et al.

Review Article | Published online: 27 Apr 2024

A review on side effect management of second generation antipsychotics to treat schizophrenia: a drug safety perspective

Wolfgang Strube et al.

Review Article | Published online: 27 Apr 2024

Analysis of Inclisiran in the US FDA adverse event reporting system (FAERS): a focus on overall patient population and Sex-specific Subgroups.

YuBin He et al.

Article | Published online: 27 Apr 2024

A Pharmacovigilance Study of adverse events associated with polymyxins based on the U.S. Food and Drug Administration adverse event reporting system (FAERS) database

Tingxi Wu et al.

Article | Published online: 27 Apr 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Drug Safety (Vol.7, Iss.5, 2008)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?